← Browse variants

HNMT 3'UTR variant

rs1050891

HNMT - The Tissue Histamine Pathway

Histamine N-methyltransferase (HNMT) is the second major enzyme for degrading
histamine in your body. While DAO works in the gut to intercept dietary histamine,
HNMT operates inside cells throughout your body - particularly in the brain, liver,
kidneys, and bronchial epithelium. It is the dominant pathway for clearing histamine
from tissues and the central nervous system.

The Mechanism

HNMT works by transferring a methyl group from S-adenosylmethionine | SAM is the body's universal methyl donor, used in hundreds of biochemical reactions (SAM) onto
histamine, converting it to N-methylhistamine, which is then further broken down
and excreted. The rs1050891 variant is located in the 3' untranslated region | The 3'UTR is a regulatory region of mRNA that affects how much protein is produced without changing the protein itself (UTR)
of the HNMT gene, which influences mRNA stability and translation efficiency.
The G allele reduces HNMT protein production, leading to slower histamine clearance
in tissues.

The Methylation Connection

Because HNMT requires SAM as a methyl donor, its function is directly tied to your
methylation capacity. If you also carry MTHFR variants (rs1801133 or rs1801131) that
reduce methylfolate production, your HNMT may be further compromised by limited
methyl group availability. | When SAM is scarce, HNMT must compete with dozens of other methyltransferases for the available supply This creates a meaningful interaction between the
methylation and histamine pathways.

The Double Hit Scenario

The most clinically significant situation arises when someone has impaired function
in both DAO and HNMT pathways. DAO handles dietary histamine in the gut; HNMT
handles endogenous and residual histamine in tissues. If both pathways are
compromised, histamine can accumulate from multiple sources simultaneously,
leading to more pronounced and persistent symptoms.

Practical Implications

Supporting HNMT function means supporting methylation: adequate B12, folate | Methylfolate (5-MTHF) is the active form that bypasses the MTHFR enzyme step entirely (ideally
as methylfolate if you have MTHFR variants), and riboflavin. If you have both
HNMT and DAO variants, a comprehensive approach addressing both diet (low histamine)
and methylation support (B vitamins) may be necessary.

All genotypes

AA normal

Normal HNMT activity

Your HNMT enzyme functions normally. This enzyme breaks down histamine in your blood and tissues (unlike DAO which works in the gut). It uses SAM (a methyl donor) as a cofactor. About 63% of Europeans share this genotype.

AG intermediate

Mildly reduced tissue histamine clearance

You carry one variant reducing HNMT activity. Histamine in your blood and tissues may clear more slowly, especially if you also have methylation issues (HNMT uses methyl groups). About 32% of Europeans share this genotype.

GG reduced

Reduced tissue histamine clearance

You have two HNMT variants. Combined with any DAO variants, this creates a "double hit" that significantly increases histamine sensitivity risk. About 5% of Europeans have this genotype.